"Nitazenes, a class of synthetic opioids, have emerged in the recreational drug supply and are associated with significant overdose fatalities, prompting their classification as Schedule I substances by the DEA."
"Etonitazene, the most potent nitazene, has 1,000-fold greater antinociceptive potency than morphine, making it unsuitable for clinical use due to overdose risks."
"Fluornitrazene (FNZ) was synthesized to explore its potential as a therapeutic agent, showing high MOR selectivity and affinity, with implications for pain management and opioid addiction treatment."
The opioid crisis has escalated due to the overprescription of opioids and the emergence of synthetic opioids, particularly nitazenes. These compounds, including etonitazene, exhibit extreme potency and have been linked to overdose fatalities, leading to their classification as Schedule I substances. Recent research has identified fluornitrazene (FNZ) as a selective MOR superagonist with high affinity and potential for therapeutic use in pain management and opioid addiction, despite its high potency making it unsuitable for clinical use without modifications.
Read at Nature
Unable to calculate read time
Collection
[
|
...
]